Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 55

1.

Relationship Between Poor Olfaction and Mortality Among Community-Dwelling Older Adults: A Cohort Study.

Liu B, Luo Z, Pinto JM, Shiroma EJ, Tranah GJ, Wirdefeldt K, Fang F, Harris TB, Chen H.

Ann Intern Med. 2019 Apr 30. doi: 10.7326/M18-0775. [Epub ahead of print]

PMID:
31035288
2.

Occupational stress and risk for Parkinson's disease: A nationwide cohort study.

Sieurin J, Andel R, Tillander A, Valdes EG, Pedersen NL, Wirdefeldt K.

Mov Disord. 2018 Sep;33(9):1456-1464. doi: 10.1002/mds.27439. Epub 2018 Aug 25.

3.

Body mass index, sitting time, and risk of Parkinson disease.

Roos E, Grotta A, Yang F, Bellocco R, Ye W, Adami HO, Wirdefeldt K, Trolle Lagerros Y.

Neurology. 2018 Apr 17;90(16):e1413-e1417. doi: 10.1212/WNL.0000000000005328. Epub 2018 Mar 21.

4.

Migraine and risk of stroke: a national population-based twin study.

Lantz M, Sieurin J, Sjölander A, Waldenlind E, Sjöstrand C, Wirdefeldt K.

Brain. 2017 Oct 1;140(10):2653-2662. doi: 10.1093/brain/awx223.

PMID:
28969391
5.

Dietary antioxidants and risk of Parkinson's disease in two population-based cohorts.

Yang F, Wolk A, Håkansson N, Pedersen NL, Wirdefeldt K.

Mov Disord. 2017 Nov;32(11):1631-1636. doi: 10.1002/mds.27120. Epub 2017 Sep 7.

6.

Genetic Variations and mRNA Expression of NRF2 in Parkinson's Disease.

Ran C, Wirdefeldt K, Brodin L, Ramezani M, Westerlund M, Xiang F, Anvret A, Willows T, Sydow O, Johansson A, Galter D, Svenningsson P, Belin AC.

Parkinsons Dis. 2017;2017:4020198. doi: 10.1155/2017/4020198. Epub 2017 May 2.

7.

A KCNC3 mutation causes a neurodevelopmental, non-progressive SCA13 subtype associated with dominant negative effects and aberrant EGFR trafficking.

Khare S, Nick JA, Zhang Y, Galeano K, Butler B, Khoshbouei H, Rayaprolu S, Hathorn T, Ranum LPW, Smithson L, Golde TE, Paucar M, Morse R, Raff M, Simon J, Nordenskjöld M, Wirdefeldt K, Rincon-Limas DE, Lewis J, Kaczmarek LK, Fernandez-Funez P, Nick HS, Waters MF.

PLoS One. 2017 May 3;12(5):e0173565. doi: 10.1371/journal.pone.0173565. eCollection 2017.

8.

Vagotomy and Parkinson disease: A Swedish register-based matched-cohort study.

Liu B, Fang F, Pedersen NL, Tillander A, Ludvigsson JF, Ekbom A, Svenningsson P, Chen H, Wirdefeldt K.

Neurology. 2017 May 23;88(21):1996-2002. doi: 10.1212/WNL.0000000000003961. Epub 2017 Apr 26.

9.

Moist smokeless tobacco (Snus) use and risk of Parkinson's disease.

Yang F, Pedersen NL, Ye W, Liu Z, Norberg M, Forsgren L, Trolle Lagerros Y, Bellocco R, Alfredsson L, Knutsson A, Jansson JH, Wennberg P, Galanti MR, Lager ACJ, Araghi M, Lundberg M, Magnusson C, Wirdefeldt K.

Int J Epidemiol. 2017 Jun 1;46(3):872-880. doi: 10.1093/ije/dyw294.

PMID:
27940486
10.

Evaluation of the interaction between LRRK2 and PARK16 loci in determining risk of Parkinson's disease: analysis of a large multicenter study.

Wang L, Heckman MG, Aasly JO, Annesi G, Bozi M, Chung SJ, Clarke C, Crosiers D, Eckstein G, Garraux G, Hadjigeorgiou GM, Hattori N, Jeon B, Kim YJ, Kubo M, Lesage S, Lin JJ, Lynch T, Lichtner P, Mellick GD, Mok V, Morrison KE, Quattrone A, Satake W, Silburn PA, Stefanis L, Stockton JD, Tan EK, Toda T, Brice A, Van Broeckhoven C, Uitti RJ, Wirdefeldt K, Wszolek Z, Xiromerisiou G, Maraganore DM, Gasser T, Krüger R, Farrer MJ, Ross OA, Sharma M; GEOPD Consortium.

Neurobiol Aging. 2017 Jan;49:217.e1-217.e4. doi: 10.1016/j.neurobiolaging.2016.09.022. Epub 2016 Oct 6.

11.

No Association Between rs7077361 in ITGA8 and Parkinson's Disease in Sweden.

Ran C, Mehdi RN, Fardell C, Xiang F, Nissbrandt H, Sydow O, Wirdefeldt K, Belin AC.

Open Neurol J. 2016 Jun 30;10:25-9. doi: 10.2174/1874205X01610010025. eCollection 2016.

12.

Authors' Reply to Lambarth: "Levodopa-Carbidopa Intestinal Gel in Patients with Parkinson's Disease: A Systematic Review".

Wirdefeldt K, Odin P, Nyholm D.

CNS Drugs. 2016 Oct;30(10):1009-10. doi: 10.1007/s40263-016-0379-7. No abstract available.

PMID:
27541606
13.

Socioeconomic status in relation to Parkinson's disease risk and mortality: A population-based prospective study.

Yang F, Johansson AL, Pedersen NL, Fang F, Gatz M, Wirdefeldt K.

Medicine (Baltimore). 2016 Jul;95(30):e4337. doi: 10.1097/MD.0000000000004337.

14.

Prodromal Markers in Parkinson's Disease: Limitations in Longitudinal Studies and Lessons Learned.

Heinzel S, Roeben B, Ben-Shlomo Y, Lerche S, Alves G, Barone P, Behnke S, Berendse HW, Bloem BR, Burn D, Dodel R, Grosset DG, Hu M, Kasten M, Krüger R, Moccia M, Mollenhauer B, Oertel W, Suenkel U, Walter U, Wirdefeldt K, Liepelt-Scarfone I, Maetzler W, Berg D.

Front Aging Neurosci. 2016 Jun 22;8:147. doi: 10.3389/fnagi.2016.00147. eCollection 2016. Review.

15.

Reduced incidence of Parkinson's disease after dipeptidyl peptidase-4 inhibitors-A nationwide case-control study.

Svenningsson P, Wirdefeldt K, Yin L, Fang F, Markaki I, Efendic S, Ludvigsson JF.

Mov Disord. 2016 Sep;31(9):1422-3. doi: 10.1002/mds.26734. Epub 2016 Jul 19. No abstract available.

PMID:
27431803
16.

Aiming for Study Comparability in Parkinson's Disease: Proposal for a Modular Set of Biomarker Assessments to be Used in Longitudinal Studies.

Lerche S, Heinzel S, Alves GW, Barone P, Behnke S, Ben-Shlomo Y, Berendse H, Bloem BR, Burn D, Dodel R, Grosset DG, Hipp G, Hu MT, Kasten M, Krüger R, Liepelt-Scarfone I, Maetzler W, Moccia M, Mollenhauer B, Oertel W, Roeben B, Walter U, Wirdefeldt K, Berg D.

Front Aging Neurosci. 2016 May 27;8:121. doi: 10.3389/fnagi.2016.00121. eCollection 2016. No abstract available.

17.

Strong association between glucocerebrosidase mutations and Parkinson's disease in Sweden.

Ran C, Brodin L, Forsgren L, Westerlund M, Ramezani M, Gellhaar S, Xiang F, Fardell C, Nissbrandt H, Söderkvist P, Puschmann A, Ygland E, Olson L, Willows T, Johansson A, Sydow O, Wirdefeldt K, Galter D, Svenningsson P, Belin AC.

Neurobiol Aging. 2016 Sep;45:212.e5-212.e11. doi: 10.1016/j.neurobiolaging.2016.04.022. Epub 2016 May 3.

18.

Depression in amyotrophic lateral sclerosis.

Roos E, Mariosa D, Ingre C, Lundholm C, Wirdefeldt K, Roos PM, Fang F.

Neurology. 2016 Jun 14;86(24):2271-7. doi: 10.1212/WNL.0000000000002671. Epub 2016 Apr 22.

19.

Levodopa-Carbidopa Intestinal Gel in Patients with Parkinson's Disease: A Systematic Review.

Wirdefeldt K, Odin P, Nyholm D.

CNS Drugs. 2016 May;30(5):381-404. doi: 10.1007/s40263-016-0336-5. Review.

PMID:
27138916
20.

Early-Life Factors and Risk of Parkinson's Disease: A Register-Based Cohort Study.

Liu B, Chen H, Fang F, Tillander A, Wirdefeldt K.

PLoS One. 2016 Apr 15;11(4):e0152841. doi: 10.1371/journal.pone.0152841. eCollection 2016.

21.

Methods in Neuroepidemiology Characterization of European Longitudinal Cohort Studies in Parkinson's Disease--Report of the JPND Working Group BioLoC-PD.

Lerche S, Liepelt-Scarfone I, Alves G, Barone P, Behnke S, Ben-Shlomo Y, Berendse H, Burn D, Dodel R, Grosset D, Heinzel S, Hu M, Kasten M, Krüger R, Maetzler W, Moccia M, Mollenhauer B, Oertel W, Roeben B, Sünkel U, Walter U, Wirdefeldt K, Berg D.

Neuroepidemiology. 2015;45(4):282-97. doi: 10.1159/000439221. Epub 2015 Nov 3.

22.

Large-scale assessment of polyglutamine repeat expansions in Parkinson disease.

Wang L, Aasly JO, Annesi G, Bardien S, Bozi M, Brice A, Carr J, Chung SJ, Clarke C, Crosiers D, Deutschländer A, Eckstein G, Farrer MJ, Goldwurm S, Garraux G, Hadjigeorgiou GM, Hicks AA, Hattori N, Klein C, Jeon B, Kim YJ, Lesage S, Lin JJ, Lynch T, Lichtner P, Lang AE, Mok V, Jasinska-Myga B, Mellick GD, Morrison KE, Opala G, Pihlstrøm L, Pramstaller PP, Park SS, Quattrone A, Rogaeva E, Ross OA, Stefanis L, Stockton JD, Silburn PA, Theuns J, Tan EK, Tomiyama H, Toft M, Van Broeckhoven C, Uitti RJ, Wirdefeldt K, Wszolek Z, Xiromerisiou G, Yueh KC, Zhao Y, Gasser T, Maraganore DM, Krüger R, Sharma M; GEO-PD Consortium.

Neurology. 2015 Oct 13;85(15):1283-92. doi: 10.1212/WNL.0000000000002016. Epub 2015 Sep 9.

23.

Personality traits and the risk for Parkinson disease: a prospective study.

Sieurin J, Gustavsson P, Weibull CE, Feldman AL, Petzinger GM, Gatz M, Pedersen NL, Wirdefeldt K.

Eur J Epidemiol. 2016 Feb;31(2):169-75. doi: 10.1007/s10654-015-0062-1. Epub 2015 Jul 1.

24.

Is a cancer diagnosis associated with subsequent risk of transient global amnesia?

Zhu J, Lu D, Sveinsson O, Wirdefeldt K, Fall K, Piehl F, Valdimarsdóttir U, Fang F.

PLoS One. 2015 Apr 7;10(4):e0122960. doi: 10.1371/journal.pone.0122960. eCollection 2015.

25.

Physical activity and risk of Parkinson's disease in the Swedish National March Cohort.

Yang F, Trolle Lagerros Y, Bellocco R, Adami HO, Fang F, Pedersen NL, Wirdefeldt K.

Brain. 2015 Feb;138(Pt 2):269-75. doi: 10.1093/brain/awu323. Epub 2014 Nov 18.

PMID:
25410713
26.

Occupational complexity and risk of Parkinson's disease.

Valdés EG, Andel R, Sieurin J, Feldman AL, Edwards JD, Långström N, Gatz M, Wirdefeldt K.

PLoS One. 2014 Sep 8;9(9):e106676. doi: 10.1371/journal.pone.0106676. eCollection 2014.

27.

Alpha-synuclein repeat variants and survival in Parkinson's disease.

Chung SJ, Biernacka JM, Armasu SM, Anderson K, Frigerio R, Aasly JO, Annesi G, Bentivoglio AR, Brighina L, Chartier-Harlin MC, Goldwurm S, Hadjigeorgiou G, Jasinska-Myga B, Jeon BS, Kim YJ, Krüger R, Lesage S, Markopoulou K, Mellick G, Morrison KE, Puschmann A, Tan EK, Crosiers D, Theuns J, Van Broeckhoven C, Wirdefeldt K, Wszolek ZK, Elbaz A, Maraganore DM; Genetic Epidemiology of Parkinson's Disease Consortium.

Mov Disord. 2014 Jul;29(8):1053-7. doi: 10.1002/mds.25841. Epub 2014 Feb 27.

28.

Familial coaggregation of Alzheimer's disease and Parkinson's disease: systematic review and meta-analysis.

Feldman AL, Johansson AL, Lambert PC, Sieurin J, Yang F, Pedersen NL, Wirdefeldt K.

Neuroepidemiology. 2014;42(2):69-80. doi: 10.1159/000355452. Epub 2013 Nov 30. Review.

29.

Evidence for modest familial co-aggregation between dementia and parkinsonism.

Feldman AL, Wirdefeldt K, Johansson AL, Gatz M, Pedersen NL.

Eur J Epidemiol. 2014 Jan;29(1):49-56. doi: 10.1007/s10654-013-9864-1. Epub 2013 Nov 19.

PMID:
24248476
30.

Parkinson's disease and cancer: A register-based family study.

Wirdefeldt K, Weibull CE, Chen H, Kamel F, Lundholm C, Fang F, Ye W.

Am J Epidemiol. 2014 Jan 1;179(1):85-94. doi: 10.1093/aje/kwt232. Epub 2013 Oct 18.

31.

Protective effect of LRRK2 p.R1398H on risk of Parkinson's disease is independent of MAPT and SNCA variants.

Heckman MG, Elbaz A, Soto-Ortolaza AI, Serie DJ, Aasly JO, Annesi G, Auburger G, Bacon JA, Boczarska-Jedynak M, Bozi M, Brighina L, Chartier-Harlin MC, Dardiotis E, Destée A, Ferrarese C, Ferraris A, Fiske B, Gispert S, Hadjigeorgiou GM, Hattori N, Ioannidis JP, Jasinska-Myga B, Jeon BS, Kim YJ, Klein C, Kruger R, Kyratzi E, Lin CH, Lohmann K, Loriot MA, Lynch T, Mellick GD, Mutez E, Opala G, Park SS, Petrucci S, Quattrone A, Sharma M, Silburn PA, Sohn YH, Stefanis L, Tadic V, Tomiyama H, Uitti RJ, Valente EM, Vassilatis DK, Vilariño-Güell C, White LR, Wirdefeldt K, Wszolek ZK, Wu RM, Xiromerisiou G, Maraganore DM, Farrer MJ, Ross OA; Genetic Epidemiology Of Parkinson's Disease (GEO-PD) Consortium.

Neurobiol Aging. 2014 Jan;35(1):266.e5-14. doi: 10.1016/j.neurobiolaging.2013.07.013. Epub 2013 Aug 17.

32.

Population-specific frequencies for LRRK2 susceptibility variants in the Genetic Epidemiology of Parkinson's Disease (GEO-PD) Consortium.

Heckman MG, Soto-Ortolaza AI, Aasly JO, Abahuni N, Annesi G, Bacon JA, Bardien S, Bozi M, Brice A, Brighina L, Carr J, Chartier-Harlin MC, Dardiotis E, Dickson DW, Diehl NN, Elbaz A, Ferrarese C, Fiske B, Gibson JM, Gibson R, Hadjigeorgiou GM, Hattori N, Ioannidis JP, Boczarska-Jedynak M, Jasinska-Myga B, Jeon BS, Kim YJ, Klein C, Kruger R, Kyratzi E, Lesage S, Lin CH, Lynch T, Maraganore DM, Mellick GD, Mutez E, Nilsson C, Opala G, Park SS, Petrucci S, Puschmann A, Quattrone A, Sharma M, Silburn PA, Sohn YH, Stefanis L, Tadic V, Theuns J, Tomiyama H, Uitti RJ, Valente EM, Van Broeckhoven C, van de Loo S, Vassilatis DK, Vilariño-Güell C, White LR, Wirdefeldt K, Wszolek ZK, Wu RM, Hentati F, Farrer MJ, Ross OA; Genetic Epidemiology of Parkinson's Disease (GEO-PD) Consortium.

Mov Disord. 2013 Oct;28(12):1740-4. doi: 10.1002/mds.25600. Epub 2013 Aug 2.

33.

Amyotrophic lateral sclerosis and cancer: a register-based study in Sweden.

Fang F, Al-Chalabi A, Ronnevi LO, Turner MR, Wirdefeldt K, Kamel F, Ye W.

Amyotroph Lateral Scler Frontotemporal Degener. 2013 Sep;14(5-6):362-8. doi: 10.3109/21678421.2013.775309. Epub 2013 Mar 26.

34.

Head injury and Parkinson's disease: a population-based study.

Fang F, Chen H, Feldman AL, Kamel F, Ye W, Wirdefeldt K.

Mov Disord. 2012 Nov;27(13):1632-5. doi: 10.1002/mds.25143. Epub 2012 Nov 9.

PMID:
23143933
35.

A multi-centre clinico-genetic analysis of the VPS35 gene in Parkinson disease indicates reduced penetrance for disease-associated variants.

Sharma M, Ioannidis JP, Aasly JO, Annesi G, Brice A, Bertram L, Bozi M, Barcikowska M, Crosiers D, Clarke CE, Facheris MF, Farrer M, Garraux G, Gispert S, Auburger G, Vilariño-Güell C, Hadjigeorgiou GM, Hicks AA, Hattori N, Jeon BS, Jamrozik Z, Krygowska-Wajs A, Lesage S, Lill CM, Lin JJ, Lynch T, Lichtner P, Lang AE, Libioulle C, Murata M, Mok V, Jasinska-Myga B, Mellick GD, Morrison KE, Meitnger T, Zimprich A, Opala G, Pramstaller PP, Pichler I, Park SS, Quattrone A, Rogaeva E, Ross OA, Stefanis L, Stockton JD, Satake W, Silburn PA, Strom TM, Theuns J, Tan EK, Toda T, Tomiyama H, Uitti RJ, Van Broeckhoven C, Wirdefeldt K, Wszolek Z, Xiromerisiou G, Yomono HS, Yueh KC, Zhao Y, Gasser T, Maraganore D, Krüger R; GEOPD consortium.

J Med Genet. 2012 Nov;49(11):721-6. doi: 10.1136/jmedgenet-2012-101155. Erratum in: J Med Genet. 2013 Mar;50(3):202.

36.

Large-scale replication and heterogeneity in Parkinson disease genetic loci.

Sharma M, Ioannidis JP, Aasly JO, Annesi G, Brice A, Van Broeckhoven C, Bertram L, Bozi M, Crosiers D, Clarke C, Facheris M, Farrer M, Garraux G, Gispert S, Auburger G, Vilariño-Güell C, Hadjigeorgiou GM, Hicks AA, Hattori N, Jeon B, Lesage S, Lill CM, Lin JJ, Lynch T, Lichtner P, Lang AE, Mok V, Jasinska-Myga B, Mellick GD, Morrison KE, Opala G, Pramstaller PP, Pichler I, Park SS, Quattrone A, Rogaeva E, Ross OA, Stefanis L, Stockton JD, Satake W, Silburn PA, Theuns J, Tan EK, Toda T, Tomiyama H, Uitti RJ, Wirdefeldt K, Wszolek Z, Xiromerisiou G, Yueh KC, Zhao Y, Gasser T, Maraganore D, Krüger R; GEO-PD Consortium.

Neurology. 2012 Aug 14;79(7):659-67. doi: 10.1212/WNL.0b013e318264e353. Epub 2012 Jul 11.

37.

CNS infections, sepsis and risk of Parkinson's disease.

Fang F, Wirdefeldt K, Jacks A, Kamel F, Ye W, Chen H.

Int J Epidemiol. 2012 Aug;41(4):1042-9. doi: 10.1093/ije/dys052. Epub 2012 Apr 19.

38.

Accuracy and sensitivity of Parkinsonian disorder diagnoses in two Swedish national health registers.

Feldman AL, Johansson AL, Gatz M, Flensburg M, Petzinger GM, Widner H, Lew MF, Pedersen NL, Wirdefeldt K.

Neuroepidemiology. 2012;38(3):186-93. doi: 10.1159/000336356. Epub 2012 Mar 29.

39.

Infection of the central nervous system, sepsis and amyotrophic lateral sclerosis.

Fang F, Chen H, Wirdefeldt K, Ronnevi LO, Al-Chalabi A, Peters TL, Kamel F, Ye W.

PLoS One. 2011;6(12):e29749. doi: 10.1371/journal.pone.0029749. Epub 2011 Dec 27.

40.

Association of LRRK2 exonic variants with susceptibility to Parkinson's disease: a case-control study.

Ross OA, Soto-Ortolaza AI, Heckman MG, Aasly JO, Abahuni N, Annesi G, Bacon JA, Bardien S, Bozi M, Brice A, Brighina L, Van Broeckhoven C, Carr J, Chartier-Harlin MC, Dardiotis E, Dickson DW, Diehl NN, Elbaz A, Ferrarese C, Ferraris A, Fiske B, Gibson JM, Gibson R, Hadjigeorgiou GM, Hattori N, Ioannidis JP, Jasinska-Myga B, Jeon BS, Kim YJ, Klein C, Kruger R, Kyratzi E, Lesage S, Lin CH, Lynch T, Maraganore DM, Mellick GD, Mutez E, Nilsson C, Opala G, Park SS, Puschmann A, Quattrone A, Sharma M, Silburn PA, Sohn YH, Stefanis L, Tadic V, Theuns J, Tomiyama H, Uitti RJ, Valente EM, van de Loo S, Vassilatis DK, Vilariño-Güell C, White LR, Wirdefeldt K, Wszolek ZK, Wu RM, Farrer MJ; Genetic Epidemiology Of Parkinson's Disease (GEO-PD) Consortium.

Lancet Neurol. 2011 Oct;10(10):898-908. doi: 10.1016/S1474-4422(11)70175-2. Epub 2011 Aug 30. Erratum in: Lancet Neurol. 2011 Oct;10(10):870.

41.

Role of sepiapterin reductase gene at the PARK3 locus in Parkinson's disease.

Sharma M, Maraganore DM, Ioannidis JP, Riess O, Aasly JO, Annesi G, Abahuni N, Bentivoglio AR, Brice A, Van Broeckhoven C, Chartier-Harlin MC, Destée A, Djarmati A, Elbaz A, Farrer M, Ferrarese C, Gibson JM, Gispert S, Hattori N, Jasinska-Myga B, Klein C, Lesage S, Lynch T, Lichtner P, Lambert JC, Lang AE, Mellick GD, De Nigris F, Opala G, Quattrone A, Riva C, Rogaeva E, Ross OA, Satake W, Silburn PA, Theuns J, Toda T, Tomiyama H, Uitti RJ, Wirdefeldt K, Wszolek Z, Gasser T, Krüger R; Genetic Epidemiology of Parkinson's Disease Consortium.

Neurobiol Aging. 2011 Nov;32(11):2108.e1-5. doi: 10.1016/j.neurobiolaging.2011.05.024. Epub 2011 Jul 22.

PMID:
21782285
42.

Occupational exposure in parkinsonian disorders: a 43-year prospective cohort study in men.

Feldman AL, Johansson AL, Nise G, Gatz M, Pedersen NL, Wirdefeldt K.

Parkinsonism Relat Disord. 2011 Nov;17(9):677-82. doi: 10.1016/j.parkreldis.2011.06.009. Epub 2011 Jul 5.

43.

Epidemiology and etiology of Parkinson's disease: a review of the evidence.

Wirdefeldt K, Adami HO, Cole P, Trichopoulos D, Mandel J.

Eur J Epidemiol. 2011 Jun;26 Suppl 1:S1-58. doi: 10.1007/s10654-011-9581-6. Epub 2011 May 28. Review.

PMID:
21626386
44.

Heritability of Parkinson disease in Swedish twins: a longitudinal study.

Wirdefeldt K, Gatz M, Reynolds CA, Prescott CA, Pedersen NL.

Neurobiol Aging. 2011 Oct;32(10):1923.e1-8. doi: 10.1016/j.neurobiolaging.2011.02.017. Epub 2011 Apr 11.

45.

Independent and joint effects of the MAPT and SNCA genes in Parkinson disease.

Elbaz A, Ross OA, Ioannidis JP, Soto-Ortolaza AI, Moisan F, Aasly J, Annesi G, Bozi M, Brighina L, Chartier-Harlin MC, Destée A, Ferrarese C, Ferraris A, Gibson JM, Gispert S, Hadjigeorgiou GM, Jasinska-Myga B, Klein C, Krüger R, Lambert JC, Lohmann K, van de Loo S, Loriot MA, Lynch T, Mellick GD, Mutez E, Nilsson C, Opala G, Puschmann A, Quattrone A, Sharma M, Silburn PA, Stefanis L, Uitti RJ, Valente EM, Vilariño-Güell C, Wirdefeldt K, Wszolek ZK, Xiromerisiou G, Maraganore DM, Farrer MJ; Genetic Epidemiology of Parkinson's Disease (GEO-PD) Consortium.

Ann Neurol. 2011 May;69(5):778-92. doi: 10.1002/ana.22321. Epub 2011 Mar 9.

46.

A large-scale genetic association study to evaluate the contribution of Omi/HtrA2 (PARK13) to Parkinson's disease.

Krüger R, Sharma M, Riess O, Gasser T, Van Broeckhoven C, Theuns J, Aasly J, Annesi G, Bentivoglio AR, Brice A, Djarmati A, Elbaz A, Farrer M, Ferrarese C, Gibson JM, Hadjigeorgiou GM, Hattori N, Ioannidis JP, Jasinska-Myga B, Klein C, Lambert JC, Lesage S, Lin JJ, Lynch T, Mellick GD, de Nigris F, Opala G, Prigione A, Quattrone A, Ross OA, Satake W, Silburn PA, Tan EK, Toda T, Tomiyama H, Wirdefeldt K, Wszolek Z, Xiromerisiou G, Maraganore DM; Genetic Epidemiology of Parkinson's disease consortium.

Neurobiol Aging. 2011 Mar;32(3):548.e9-18. doi: 10.1016/j.neurobiolaging.2009.11.021. Epub 2009 Dec 24.

47.

Non-replication of association for six polymorphisms from meta-analysis of genome-wide association studies of Parkinson's disease: large-scale collaborative study.

Evangelou E, Maraganore DM, Annesi G, Brighina L, Brice A, Elbaz A, Ferrarese C, Hadjigeorgiou GM, Krueger R, Lambert JC, Lesage S, Markopoulou K, Mellick GD, Meeus B, Pedersen NL, Quattrone A, Van Broeckhoven C, Sharma M, Silburn PA, Tan EK, Wirdefeldt K, Ioannidis JP; Genetic Epidemiology of Parkinson's Disease (GEOPD) Consortium.

Am J Med Genet B Neuropsychiatr Genet. 2010 Jan 5;153B(1):220-8. doi: 10.1002/ajmg.b.30980.

48.

Phenotypically concordant and discordant monozygotic twins display different DNA copy-number-variation profiles.

Bruder CE, Piotrowski A, Gijsbers AA, Andersson R, Erickson S, Diaz de Ståhl T, Menzel U, Sandgren J, von Tell D, Poplawski A, Crowley M, Crasto C, Partridge EC, Tiwari H, Allison DB, Komorowski J, van Ommen GJ, Boomsma DI, Pedersen NL, den Dunnen JT, Wirdefeldt K, Dumanski JP.

Am J Hum Genet. 2008 Mar;82(3):763-71. doi: 10.1016/j.ajhg.2007.12.011. Epub 2008 Feb 14.

49.

Complete ascertainment of Parkinson disease in the Swedish Twin Registry.

Wirdefeldt K, Gatz M, Bakaysa SL, Fiske A, Flensburg M, Petzinger GM, Widner H, Lew MF, Welsh M, Pedersen NL.

Neurobiol Aging. 2008 Dec;29(12):1765-73. Epub 2007 May 29.

50.

Lack of replication of thirteen single-nucleotide polymorphisms implicated in Parkinson's disease: a large-scale international study.

Elbaz A, Nelson LM, Payami H, Ioannidis JP, Fiske BK, Annesi G, Carmine Belin A, Factor SA, Ferrarese C, Hadjigeorgiou GM, Higgins DS, Kawakami H, Krüger R, Marder KS, Mayeux RP, Mellick GD, Nutt JG, Ritz B, Samii A, Tanner CM, Van Broeckhoven C, Van Den Eeden SK, Wirdefeldt K, Zabetian CP, Dehem M, Montimurro JS, Southwick A, Myers RM, Trikalinos TA.

Lancet Neurol. 2006 Nov;5(11):917-23.

Supplemental Content

Loading ...
Support Center